Therapeutic equivalence of intravenous and intramuscular dosage forms of Cortexin in ischemic strokes
Randomized study in people · 2025
- What was studied
- 490 stroke patients: 246 IV-first, 244 IM; double-dummy active comparison
- Main finding
- Compares routes of active Cortexin administration. Both groups received active drug; the placebo injections maintained masking.
mRS 0–2 at day 90 · 93.64% IV-form versus 86.50% IM-form
Reported findings and study design
490 stroke patients aged 30–80: IV-form Cortexin 246 versus IM-form Cortexin 244. Mean age 63.97 ± 8.5 years; 54.1% men, 45.9% women. Two ten-day courses with ten days between; follow-up 90 days. Both groups received active Cortexin.
Population or model 490 stroke patients: 246 IV-first, 244 IM; double-dummy active comparison
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| mRS 0–2 at day 90 | 93.64% IV-form versus 86.50% IM-form | |
| NIHSS reduction | 3.93 versus 3.72 points | |
| MMSE increase | 4.11 versus 3.88 points | p=0.249 |
| Adverse events | 74 events in 60 IV-group patients versus 51 in 41 IM-group patients | p>0.05 |
The first course used 10 mg twice daily by the assigned active route with matching placebo by the other route; both then received IM Cortexin. This tests route/form equivalence, not efficacy versus no Cortexin.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- This is an active-route equivalence comparison, not evidence of benefit versus no Cortexin.
- Noninferiority margin and full analysis require review; publication year is 2025 despite later indexing.
Source details
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Sources checked
Citation
Fedin AI, Khairova EN, Artyukov OP, Timchenko LV, Bazhenova OA, Gaiduk NV, Zykov MV. Therapeutic equivalence of intravenous and intramuscular dosage forms of Cortexin in ischemic strokes Zh Nevrol Psikhiatr Im S S Korsakova 125(12):60-67. PMID 41524350
Study source ↗ · DOI 10.17116/jnevro202512512160 · Bibliography entry · Link to this summary